A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Alector, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 455 shares of ALEC stock, worth $2,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares
455
Previous 455 -0.0%
Holding current value
$2,238
Previous $2.74 Million 99.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.69 - $8.08 $2,588 - $3,676
455 New
455 $2.74 Million
Q3 2023

Aug 14, 2024

BUY
$5.2 - $8.77 $208 - $350
40 Added 9.64%
455 $2.95 Million
Q1 2022

Aug 14, 2024

SELL
$13.02 - $20.78 $520 - $831
-40 Reduced 8.79%
415 $5.91 Million
Q2 2021

Aug 30, 2024

SELL
$15.5 - $22.48 $620 - $899
-40 Reduced 8.79%
415 $8.64 Million
Q1 2021

Aug 30, 2024

SELL
$14.84 - $22.23 $593 - $889
-40 Reduced 8.79%
415 $8.36 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $406M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.